Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced or Metastatic Non-Small-Cell Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07003321
What this trial is testing

A Trial of HRS-4508 in Subjects With Locally Advanced or Metastatic Non-small Cell Lung Cancer

Who this might be right for
Solid Tumor
Jiangsu HengRui Medicine Co., Ltd. 120
Testing effectiveness (Phase 2)UnknownNCT00006215
What this trial is testing

Docetaxel and Vinorelbine Plus Filgrastim in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Amgen
Testing effectiveness (Phase 2)Looking for participantsNCT06394674
What this trial is testing

High-dose Furmonertinib in the Treatment in Patients With Advanced, Metastatic NSCLC With Progressed After First- or Second-line Treatment With Osimertinib

Who this might be right for
Non-Small Cell Lung Cancer
Changhai Hospital 84
Testing effectiveness (Phase 2)Active Not RecruitingNCT05256290
What this trial is testing

Phase 1/2 Study of Silevertinib (BDTX-1535) in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutations

Who this might be right for
Non-Small Cell Lung CancerAdvanced Non-Small Cell Squamous Lung CancerMetastatic Lung Non-Small Cell Carcinoma+7 more
Black Diamond Therapeutics, Inc. 200
Testing effectiveness (Phase 2)Looking for participantsNCT06953089
What this trial is testing

DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

Who this might be right for
Solid Tumors
DualityBio Inc. 450
Testing effectiveness (Phase 2)Study completedNCT00661778
What this trial is testing

Avastin (Bevacizumab) in Combination With Docetaxel and Cisplatin in Patients With Metastatic or Locally Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Hoffmann-La Roche 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT06879717
What this trial is testing

Roginolisib (IOA-244) in Combination With Dostarlimab With or Without Docetaxel in Metastatic Non Small-cell Lung Cancer (NSCLC) Patients

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer (NSCLC)Advanced Non Squamous NSCLC
iOnctura 45
Early research (Phase 1)Ended earlyNCT04965818
What this trial is testing

Phase 1b/2 Study of Futibatinib in Combination With Binimetinib in Patients With Advanced KRAS Mutant Cancer

Who this might be right for
Advanced or Metastatic Solid Tumors Irrespective of Gene AlterationsNon-Small Cell Lung CancerKRAS Gene Mutation
Taiho Oncology, Inc. 38
Early research (Phase 1)Study completedNCT01302808
What this trial is testing

Romidepsin and Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung CancerMetastatic Cancer
University of Texas Southwestern Medical Center 17
Early research (Phase 1)Looking for participantsNCT05504278
What this trial is testing

Efficacy and Safety of IBI351 in Combination With Chemotherapy in Advanced Non-squamous Non-small Cell Lung Cancer Subjects With KRAS G12C Mutation

Who this might be right for
Advanced Non-Small Cell Lung Cancer
Innovent Biologics (Suzhou) Co. Ltd. 144
Not applicableStudy completedNCT01795352
What this trial is testing

Retrospective Study in a NSCLC M+ p

Who this might be right for
EGFR Mutated Non-small Cell Lung Cancer Patients
AstraZeneca 187
Early research (Phase 1)UnknownNCT04772235
What this trial is testing

Phase I Study of Repotrectinib and Osimertinib in NSCLC Patients

Who this might be right for
Nsclc
Instituto Oncológico Dr Rosell 32
Testing effectiveness (Phase 2)Study completedNCT00651508
What this trial is testing

Study to Evaluate KOS-1584 in Patients With Advanced or Metastatic Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung Cancer
Bristol-Myers Squibb 1
Large-scale testing (Phase 3)Looking for participantsNCT07149649
What this trial is testing

Magnesium Supplementation in Advanced Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Metastatic NSCLC - Non-Small Cell Lung Cancer
Swiss Cancer Institute 230
Early research (Phase 1)Looking for participantsNCT06332755
What this trial is testing

Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLC

Who this might be right for
Non-small Cell Lung Cancer(NSCLC)Head and Neck Squamous Cell Carcinoma(HNSCC)Renal Cell Carcinoma(RCC)+2 more
LG Chem 76
Large-scale testing (Phase 3)UnknownNCT00706862
What this trial is testing

Safety and Efficacy of Talactoferrin in Addition to Standard Chemotherapy in Patients With Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Agennix 1,100
Early research (Phase 1)Study completedNCT01390818
What this trial is testing

Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Locally Advanced Solid TumorMetastatic Solid TumorBreast Cancer+3 more
EMD Serono 146
Large-scale testing (Phase 3)Looking for participantsNCT06875310
What this trial is testing

Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Mirati Therapeutics Inc. 630
Early research (Phase 1)UnknownNCT04448379
What this trial is testing

Efficacy and Safety of JMT101 Combined With Afatinib (or Osimertinib) in Patients With Non-Small Cell Lung Cancer

Who this might be right for
Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Shanghai JMT-Bio Inc. 48
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06182761
What this trial is testing

Sunvozertinib Combined With Anlotinib in Local Advanced or Metastatic Non-small Cell Lung Cancer

Who this might be right for
NSCLC
Shanghai Zhongshan Hospital 45
Next Page